Last reviewed · How we verify
Administration of a PET radiotracer — Competitive Intelligence Brief
phase 2
Nuclear Medicine
Small molecule
Live · refreshed every 30 min
Target snapshot
Administration of a PET radiotracer (Administration of a PET radiotracer) — Hospices Civils de Lyon. This PET radiotracer is used to visualize and diagnose various diseases by emitting radiation that can be detected by a PET scanner.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Administration of a PET radiotracer TARGET | Administration of a PET radiotracer | Hospices Civils de Lyon | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Administration of a PET radiotracer CI watch — RSS
- Administration of a PET radiotracer CI watch — Atom
- Administration of a PET radiotracer CI watch — JSON
- Administration of a PET radiotracer alone — RSS
Cite this brief
Drug Landscape (2026). Administration of a PET radiotracer — Competitive Intelligence Brief. https://druglandscape.com/ci/administration-of-a-pet-radiotracer. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab